Jaguar Health, Inc. Investor Presentation January 2019 Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding the Company's plan to file an IND in 2H 2019 for lechlemer for the possible indication of diarrhea caused by cholera, the Company's belief that lechlemer may offer a possible Priority Review Voucher opportunity, the Company's statements regarding planned ...